Finance

Lists
Why is SRZN down 4.65%?
Dive Deeper
SRZN:NASDAQ
Surrozen Inc
$25.14
-4.65%
(-1.23) 1D
Oct 7, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SRZN...
Open
$25.81
High
$26.21
Low
$25.08
Mkt. cap
295.54M
Avg. vol.
736.27K
Volume
374.29K
52-wk high
$37.83
52-wk low
$11.39
EPS
-$35.79
Beta
0.47
Shares outstanding
11.75M
No. of employees
44
Open
$25.81
High
$26.21
Low
$25.08
Mkt. cap
295.54M
Avg. vol.
736.27K
Volume
374.29K
52-wk high
$37.83
52-wk low
$11.39
EPS
-$35.79
Beta
0.47
Shares outstanding
11.75M
No. of employees
44
News stories
From web sources and news partners
About Surrozen Inc
CEO-
Employees44
Founded2015
HeadquartersSouth San Francisco, California, United States
SectorBiotechnology
Websitesurrozen.com
Analyst ratings
Based on 5 analysts giving stock ratings to SRZN in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for SRZN in the last 3 months.
Highest
Current $25.14
$54.00 (+114.75%)
Average
$47.50 (+88.90%)
Lowest
$40.00 (+59.08%)
Analyst
Recommendation
Action
Price target
Projected
Date
Lachlan Hanbury Brown
William Blair
Buy
Maintained
-
-
10/02/2026
Matthew Caufield
H.C. Wainwright
Buy
Reiterated
$54.00
+114.8%
09/25/2026
Patrick Dolezal
LifeSci Capital
Buy
Reiterated
$54.00
+114.8%
09/26/2026
Unknown Analyst
Guggenheim
Buy
Reiterated
$42.00
+67%
08/13/2026
Steven Seedhouse
Cantor Fitzgerald
Buy
Maintained
$40.00
+59.1%
08/06/2026
Phil Nadeau
TD Cowen
Buy
Maintained
-
-
05/07/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
983.00K
528.00K
5.00M
5.00M
Cost of goods sold
7.77M
8.99M
9.33M
8.48M
Cost of revenue
7.77M
8.99M
9.33M
8.48M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.09M
4.18M
6.13M
6.89M
Operating expense
4.09M
4.18M
6.13M
6.89M
Total operating expenses
11.87M
13.17M
15.46M
15.37M
Operating income
-10.88M
-12.64M
-10.46M
-10.37M
Other non operating income
-61.67M
-171.31M
-117.96M
59.61M
EBT including unusual items
-71.64M
-183.16M
-127.50M
50.18M
EBT excluding unusual items
-71.64M
-183.16M
-127.50M
50.18M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-71.64M
-183.16M
-127.50M
50.18M
Net profit margin
-7,288.20%
-34,689.20%
-2,550.10%
1,003.54%
Earnings per share
-3.60
-9.62
-4.63
-2.10
Interest and investment income
911.00K
788.00K
912.00K
938.00K
Interest expense
-
-
-
-
Net interest expenses
911.00K
788.00K
912.00K
938.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-10.82M
-12.59M
-10.39M
-10.32M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps